Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Guidelines for the management of lyme disease : the controversy and the quandary.

Literature DB >> 18062716

Guidelines for the management of lyme disease : the controversy and the quandary.

William R Bowie¹.

Abstract

Entities: Disease

Mesh：

Substances：
Anti-Infective Agents

Year: 2007 PMID： 18062716 DOI： 10.2165/00003495-200767180-00002

Source DB: PubMed Journal: Drugs ISSN： 0012-6667 Impact factor: 9.546

× No keyword cloud information.

12 in total

1. Intralaboratory reliability of serologic and urine testing for Lyme disease.

Authors: M S Klempner; C H Schmid; L Hu; A C Steere; G Johnson; B McCloud; R Noring; A Weinstein
Journal: Am J Med Date: 2001-02-15 Impact factor: 4.965

2. Treating post Lyme disease: trying to solve one equation with too many unknowns.

Authors: Israel Steiner
Journal: Neurology Date: 2003-06-24 Impact factor: 9.910

3. Evidence-based guidelines for the management of Lyme disease.

Authors: Daniel Cameron; Andrea Gaito; Nick Harris; Gregory Bach; Sabra Bellovin; Kenneth Bock; Steven Bock; Joseph Burrascano; Constance Dickey; Richard Horowitz; Steven Phillips; Laurence Meer-Scherrer; Bernard Raxlen; Virginia Sherr; Harold Smith; Pat Smith; Raphael Stricker
Journal: Expert Rev Anti Infect Ther Date: 2004 Impact factor: 5.091

4. The evidence-based health care debate - 2006. Where are we now?

Authors: Andrew Miles; Andreas Polychronis; Joseph E Grey
Journal: J Eval Clin Pract Date: 2006-06 Impact factor: 2.431

5. Guidance for guidelines.

Authors: Robert Steinbrook
Journal: N Engl J Med Date: 2007-01-25 Impact factor: 91.245

Review 6. Evidence-based medicine: fifteen years later. Golem the good, the bad, and the ugly in need of a review?

Authors: Milos Jenicek
Journal: Med Sci Monit Date: 2006-11

7. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.

Authors: Gary P Wormser; Raymond J Dattwyler; Eugene D Shapiro; John J Halperin; Allen C Steere; Mark S Klempner; Peter J Krause; Johan S Bakken; Franc Strle; Gerold Stanek; Linda Bockenstedt; Durland Fish; J Stephen Dumler; Robert B Nadelman
Journal: Clin Infect Dis Date: 2006-10-02 Impact factor: 9.079

Review 8. Point: antibiotic therapy is not the answer for patients with persisting symptoms attributable to lyme disease.

Authors: Paul G Auwaerter
Journal: Clin Infect Dis Date: 2007-06-05 Impact factor: 9.079

Guidelines for the management of lyme disease : the controversy and the quandary.

1. Intralaboratory reliability of serologic and urine testing for Lyme disease.

2. Treating post Lyme disease: trying to solve one equation with too many unknowns.

3. Evidence-based guidelines for the management of Lyme disease.

4. The evidence-based health care debate - 2006. Where are we now?

5. Guidance for guidelines.

Review 6. Evidence-based medicine: fifteen years later. Golem the good, the bad, and the ugly in need of a review?

7. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.

Review 8. Point: antibiotic therapy is not the answer for patients with persisting symptoms attributable to lyme disease.

9. Cognitive function in post-treatment Lyme disease: do additional antibiotics help?

10. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial.

1. Lyme disease in Canada: Q & A for paediatricians.

2. Lyme disease in Canada: Q & A for paediatricians.

3. Laboratory diagnostics for Lyme disease.

4. Evolving perspectives on lyme borreliosis in Canada.